SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-09-067001
Filing Date
2009-12-31
Accepted
2009-12-31 11:56:53
Documents
14
Period of Report
2009-12-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v170293_8k.htm 8-K 39237
2 v170293_ex10-1.htm EX-10.1 1572
3 GRAPHIC v170293_ex10-1x1x1.jpg GRAPHIC 78996
4 GRAPHIC v170293_ex10-1x2x1.jpg GRAPHIC 116594
5 GRAPHIC v170293_ex10-1x3x1.jpg GRAPHIC 107414
6 GRAPHIC v170293_ex10-1x4x1.jpg GRAPHIC 118511
7 GRAPHIC v170293_ex10-1x5x1.jpg GRAPHIC 122948
8 GRAPHIC v170293_ex10-1x6x1.jpg GRAPHIC 44350
9 GRAPHIC v170293_ex10-1x8x1.jpg GRAPHIC 38846
10 GRAPHIC v170293_ex10-1x9x1.jpg GRAPHIC 28813
11 v170293_ex10-2.htm EX-10.2 822
12 GRAPHIC v170293_ex10-2x1x1.jpg GRAPHIC 97409
13 GRAPHIC v170293_ex10-2x2x1.jpg GRAPHIC 84436
14 GRAPHIC v170293_ex10-2x3x1.jpg GRAPHIC 35823
  Complete submission text file 0001144204-09-067001.txt   1249522
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10019
Business Address 110 EAST 59TH STREET NEW YORK NY 10019 250-519-0553
BRAINSTORM CELL THERAPEUTICS INC (Filer) CIK: 0001137883 (see all company filings)

IRS No.: 912061050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-61610 | Film No.: 091267894
SIC: 2836 Biological Products, (No Diagnostic Substances)